Conformational analysis of the 1,4-dihydropyridines linking the structural aspects to the biological binding event: a study of the receptor-site conformation

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

Michael J. S. Dewar, Eve G. Zoebisch, Eamonn F. Healy et al. · Journal of the American Chemical Society · 1985 · 13.1K citations

Engineering, Altmetric Attention Score, Molecular Biology +18

Hantzsch-type dihydropyridine hypotensive agents

Bernard Loev, M. M. GOODMAN, Kenneth M. Snader et al. · Journal of Medicinal Chemistry · 1974 · 344 citations

Engineering, Altmetric Attention Score, Bibliometrics +20

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine

A. M. Triggle, Eli Shefter, David J. Triggle · Journal of Medicinal Chemistry · 1980 · 175 citations

Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine

Rune Fossheim, Knut Svarteng, Arvid Mostad et al. · Journal of Medicinal Chemistry · 1982 · 153 citations

1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach

Robert A. Coburn, Mark Wierzba, Mark J. Suto et al. · Journal of Medicinal Chemistry · 1988 · 122 citations